CurrentRheuma coverage · page 4 of 23

RMD Open

Briefs 121–160 of 899 CurrentRheuma has covered from this journal, newest publication first

Latest from RMD Open

All coverage, newest first

RMD Open29 Apr 2026
Development and validation of a new ultrasound score (SONAR-7) for synovitis in psoriatic arthritis and axial spondyloarthritis
Diagnostic or prognostic studySpondyloarthritis & PsA
RMD Open28 Apr 2026
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohort
Cohort studyRA
RMD Open28 Apr 2026
Cognitive impairment risk in patients with rheumatoid arthritis: a population-based cohort study
Cohort studyRA
RMD Open24 Apr 2026
Factors associated with radiographic progression of hand osteoarthritis over 2 years
Cohort studyOsteoarthritis
RMD Open24 Apr 2026
Early methylprednisolone pulses and prevention of long-term damage accrual in active systemic lupus erythematosus: a propensity score analysis of the Lupus–Cruces–Bordeaux cohort
Cohort studyLupus & APS
RMD Open24 Apr 2026
Sustaining remission in rheumatoid arthritis: the role of clinical deep remission and its implications for drug tapering
Cohort studyRA
RMD Open13 Apr 2026
Renal involvement in ankylosing spondylitis: a retrospective, population-based cohort study using data from the TriNetX Global Network
Cohort studySpondyloarthritis & PsA
RMD Open10 Apr 2026
Spinal mobility and functional limitations in patients with diffuse idiopathic skeletal hyperostosis compared to healthy controls and patients with axial spondyloarthritis
Cross-sectional studySpondyloarthritis & PsA
RMD Open10 Apr 2026
Effect of secukinumab dose escalation on MRI-detected inflammation and structural damage in axial spondyloarthritis: a clinical, investigator-initiated, treat-to-target study (TRACE)
Research articleSpondyloarthritis & PsA
RMD Open10 Apr 2026
Immunoprecipitation-mass spectrometry reveals known and novel (NatC, BCS1L ) antinuclear antibodies in rheumatoid arthritis
Mechanistic studyRA
RMD Open9 Apr 2026
Emotional well-being at diagnosis may indicate future mental health risk in patients with juvenile idiopathic arthritis: data from the German inception cohort ICON
Cohort studyPediatric
RMD Open9 Apr 2026
Birth length and perinatal exposures and rheumatoid arthritis risk in the E3N cohort
Cohort studyRA
RMD Open9 Apr 2026
Severe thrombocytopenia in antiphospholipid syndrome: a retrospective study of 432 patients
Cohort studyLupus & APS
RMD Open9 Apr 2026
Persistent arthritis develops in joints previously affected by palindromic flares: a longitudinal study investigating the transition from palindromic rheumatism to rheumatoid arthritis
Cohort studyRA
RMD Open2 Apr 2026
Sustained exposure to low- and high-income status and risk of all-cause mortality in individuals with rheumatoid arthritis: a population-based retrospective cohort study from 2010 to 2020
Cohort studyRA
RMD Open27 Mar 2026
Complete PET/CT extinction and subsequent risk of aortic dilation in patients with giant cell arteritis-related large vessel vasculitis treated with tocilizumab
Cohort studyVasculitis & PMR
RMD Open26 Mar 2026
Reducing selection bias while maintaining precision through an integrated analysis: 2-year longitudinal analysis of imaging outcomes in the SPondyloArthritis Caught Early cohort
Cohort studySpondyloarthritis & PsA
RMD Open25 Mar 2026
Real-world safety assessment of avacopan in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Research articleVasculitis & PMR
RMD Open24 Mar 2026
Comparative effectiveness and predictors of remission between adalimumab and ixekizumab in patients with psoriatic arthritis: findings from the ‘AIRE’ multicentre study
Cohort studySpondyloarthritis & PsA
RMD Open24 Mar 2026
Pericoronary fat attenuation and its association with atherosclerosis in rheumatoid arthritis compared with controls: a cross-sectional study
Cross-sectional studyRA
RMD Open24 Mar 2026
Prevalence, incidence, mortality and causes of death in a large cohort of patients with rheumatoid arthritis: an Italian population-based study
Cohort studyRA
RMD Open24 Mar 2026
Severe impairments in work ability among patients with axSpA and PsA: results from the RABBIT-SpA Register
Cross-sectional studySpondyloarthritis & PsA
RMD Open23 Mar 2026
Increased synovial and entheseal fibroblast activation detected by 68 Ga-FAPI-PET/CT is associated with the development of psoriatic arthritis in psoriasis patients with arthralgia
Cohort studySpondyloarthritis & PsA
RMD Open19 Mar 2026
Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial
Randomized controlled trialAcross diseases
RMD Open19 Mar 2026
Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review
Cohort studyLupus & APS
RMD Open19 Mar 2026
Effect of targeted therapies on pulmonary function in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
Meta-analysisRA
RMD Open16 Mar 2026
Can alternative means of phenotyping rheumatoid arthritis reduce its apparent heterogeneity? A comparison of three disease activity classifications with DAS28
Cross-sectional studyRA
RMD Open13 Mar 2026
Hyposplenism in systemic lupus erythematosus: biological and radiological characteristics and its association with increased risk of infection
Case-control studyLupus & APS
RMD Open13 Mar 2026
Mortality incidence in spondyloarthritis: real-world evidence using the TriNetX Global Collaborative Network
Cohort studySpondyloarthritis & PsA
RMD Open13 Mar 2026
Autoantibody biomarkers and first-line therapy response in RA: findings from the CAP48 cohort
Cohort studyRA
RMD Open13 Mar 2026
Association between SARC-F as a self-report screening tool for sarcopenia and muscle strength, physical performance, daily activity, patient-reported outcomes and body composition in patients with spondyloarthritis
Cross-sectional studySpondyloarthritis & PsA
RMD Open10 Mar 2026
Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studies
Research articleSpondyloarthritis & PsA
RMD Open9 Mar 2026
2016 sJIA-MAS criteria and a step-up therapeutic approach in KD-MAS: insights from a combined cohort and literature review
Cohort studyPediatric
RMD Open9 Mar 2026
Inflammation response criteria for rheumatoid arthritis based on the two-component disease activity score
Diagnostic or prognostic studyRA
RMD Open9 Mar 2026
Which definitions for MRI sacroiliac joint lesions predict the diagnosis of early axial spondyloarthritis best? A 2-year follow-up in the SPACE cohort
Diagnostic or prognostic studySpondyloarthritis & PsA
RMD Open9 Mar 2026
Clinical phenotype and long-term damage in paediatric Behçet’s disease: comparative performance of ISG, ICBD and PEDBD classification criteria in a retrospective endemic cohort
Cohort studyPediatric
RMD Open5 Mar 2026
Effectiveness of TNF inhibitors in patients with very early axial spondyloarthritis, defined as duration of ≤1 year of back pain: longitudinal observational data from the SCQM registry
Cohort studySpondyloarthritis & PsA
RMD Open4 Mar 2026
Head and neck cancer risk in patients with rheumatoid arthritis compared with matched controls: a nationwide cohort study
Cohort studyRA
RMD Open4 Mar 2026
Nipocalimab and certolizumab combination therapy in participants with active rheumatoid arthritis despite prior treatment with advanced therapies: results from the phase 2a DAISY-RA study
Randomized controlled trialRA
RMD Open4 Mar 2026
CAR-T cell therapy for treatment-refractory rheumatic autoimmune diseases: a systematic review of clinical outcomes and safety profiles
Meta-analysisAcross diseases

All 899 Briefs in ExploreShowing Briefs 121–160 of 899, newest first